Heparin
-
Upload
hozan-faeq -
Category
Documents
-
view
425 -
download
0
description
Transcript of Heparin
![Page 1: Heparin](https://reader034.fdocuments.in/reader034/viewer/2022051109/5492e27db47959ad258b46ad/html5/thumbnails/1.jpg)
Heparin
![Page 2: Heparin](https://reader034.fdocuments.in/reader034/viewer/2022051109/5492e27db47959ad258b46ad/html5/thumbnails/2.jpg)
Whats Heparin:
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots.
Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. Heparin is also used before surgery to reduce the risk of
blood clots
![Page 3: Heparin](https://reader034.fdocuments.in/reader034/viewer/2022051109/5492e27db47959ad258b46ad/html5/thumbnails/3.jpg)
Heparin – the molecule
heparin is heterogeneous of un branched polysaccharide chains
Alternating monosaccaride units of L-iduronic acid and D-glucosamine
one third of the polysaccharide chain contain a specific antithrombin binding pentasaccharide sequence
![Page 4: Heparin](https://reader034.fdocuments.in/reader034/viewer/2022051109/5492e27db47959ad258b46ad/html5/thumbnails/4.jpg)
Heparin – the source
preparation from porcine and bovine intestinal mucous
- preparation from bovine lung
![Page 5: Heparin](https://reader034.fdocuments.in/reader034/viewer/2022051109/5492e27db47959ad258b46ad/html5/thumbnails/5.jpg)
Mechanism of action :
Heparin exerts parts of its anticoagulant activity through interaction with antithrombin
antithrombin binds specifically to a pentsaccharide in heparin
binding to heparin induced a conformational change in the antithrombin , which accelerate enzyme inhibition
![Page 6: Heparin](https://reader034.fdocuments.in/reader034/viewer/2022051109/5492e27db47959ad258b46ad/html5/thumbnails/6.jpg)
![Page 7: Heparin](https://reader034.fdocuments.in/reader034/viewer/2022051109/5492e27db47959ad258b46ad/html5/thumbnails/7.jpg)
Forms of heparin :
1- unfractionated heparin (UF)
2- low molecular weight heparin (LMW)
![Page 8: Heparin](https://reader034.fdocuments.in/reader034/viewer/2022051109/5492e27db47959ad258b46ad/html5/thumbnails/8.jpg)
Trade Names
. Heparin Sodium
. Heparin I.V. Flush
. Monoject PreFill Advanced (this form of heparin must not be used to treat or prevent blood clotting in the body )
![Page 9: Heparin](https://reader034.fdocuments.in/reader034/viewer/2022051109/5492e27db47959ad258b46ad/html5/thumbnails/9.jpg)
Pharmacokinetics:
Absorption: Heparin is not absorbed from GI; must be given IV or subcutaneously,
Metabolism: The liver andreticuloendothelial system are the sites of biotransformation.
Elimination: The average half-life is 1.5 h (range, 1 to 6 h) and is dose dependent Excreted in the urine
![Page 10: Heparin](https://reader034.fdocuments.in/reader034/viewer/2022051109/5492e27db47959ad258b46ad/html5/thumbnails/10.jpg)
Indications and Usage:
- Prophylaxis and treatment of venous thrombosis and it extensions
- pulmonary embolism (PE), peripheral arterial embolism, and atrial fibrillation with embolization.
- treatment of acute and chronic consumption coagulopathies (disseminated intravascular coagulation [DIC])
![Page 11: Heparin](https://reader034.fdocuments.in/reader034/viewer/2022051109/5492e27db47959ad258b46ad/html5/thumbnails/11.jpg)
- prevention of postoperative deep venous thrombosis
- Also used to maintain catheter patency and as an anticoagulant in blood transfusions, extracorporeal circulation, dialysis, and laboratory samples.
![Page 12: Heparin](https://reader034.fdocuments.in/reader034/viewer/2022051109/5492e27db47959ad258b46ad/html5/thumbnails/12.jpg)
Dosage and Administration:
- intravenously (immediate effect) - 20 to 40 thousands units/day dose
- subcutaneously ( effect on 20-60 min ) -8,000 to 10,000 units every 8 h .
![Page 13: Heparin](https://reader034.fdocuments.in/reader034/viewer/2022051109/5492e27db47959ad258b46ad/html5/thumbnails/13.jpg)
![Page 14: Heparin](https://reader034.fdocuments.in/reader034/viewer/2022051109/5492e27db47959ad258b46ad/html5/thumbnails/14.jpg)
Contraindications :
- Severe thrombocytopenia
- Patients in whom suitable blood coagulation tests cannot be performed.
- Hypersensitivity to heparin or any other product ingredients.
![Page 15: Heparin](https://reader034.fdocuments.in/reader034/viewer/2022051109/5492e27db47959ad258b46ad/html5/thumbnails/15.jpg)
- do not administer products containing benzyl alcohol as a perseverative to neonates, infants, pregnant women, or breast-feeding women
- Patients with hypersensitivity to corn products and bisulfites (may be contained in some heparin sodium in dextrose 5%
![Page 16: Heparin](https://reader034.fdocuments.in/reader034/viewer/2022051109/5492e27db47959ad258b46ad/html5/thumbnails/16.jpg)
Drug interactions
interaction with :
- Alteplase
- Antihistamines
- Antithrombin
- Cephalosporins (eg, cefazolin, ceftriaxone)
- Penicillins, parenteral (eg, ampicillin, penicillin G)
![Page 17: Heparin](https://reader034.fdocuments.in/reader034/viewer/2022051109/5492e27db47959ad258b46ad/html5/thumbnails/17.jpg)
Adverse Reactions
-Hematologic:Hematologic side effects including hemorrhage at any site have been reported the most frequently.
-Cardiovascular:Cardiovascular side effects have included new or recurrent arterial and venous thrombosis in association with thrombocytopenia.
-Dermatologic:Dermatologic side effects have included extensive skin necrosis, necrotic lesions at subcutaneous injection sites
![Page 18: Heparin](https://reader034.fdocuments.in/reader034/viewer/2022051109/5492e27db47959ad258b46ad/html5/thumbnails/18.jpg)
-Musculoskeletal : Musculoskeletal side effects have
included osteoporosis
-Endocrine: Endocrine side effects have included increased free thyroxine levels. Acute adrenal insufficiency caused by heparin induced adrenal hemorrhage has been reported
![Page 19: Heparin](https://reader034.fdocuments.in/reader034/viewer/2022051109/5492e27db47959ad258b46ad/html5/thumbnails/19.jpg)
Thank you